GLP1R and coronary artery disorder: It may also be useful to consider additional relevant effects of GLP1R agonism, such as reduced inflammation, blood pressure, and triglyceride levels, in order to further understand the mechanisms by which GLP1 agonists exert their effects on reducing CAD risk.